For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban. Data remain inconclusive regarding ...

Please provide your email address to receive an email when new articles are posted on . Treatment of venous thromboembolism with apixaban was tied to lower bleeding risk vs. rivaroxaban. Adherence to ...

One winner emerged from a direct comparison of direct oral anticoagulants (DOACs) for patients with acute venous thromboembolism, based on the COBRRA randomized trial. Safety events favored apixaban ...

Apixaban and rivaroxaban are the oral anticoagulants most frequently used to treat acute venous thromboembolism. However, uncertainty remains about the difference in bleeding risk between the two ...